POSTER SESSIONS ABSTRACTS
Poster Session X
P-10
PHARMACOLOGY OF INFLAMMATION
| P-10/1 | Abstract ritirato |
| P-10/2 | Glucocorticoid-Induced
Leucine Zipper (GILZ) controls T lymphocytes differentiation O. Bereshchenko, M. Coppo, M. Cimino, M. Di Sante, A. Venanzi, S. Bruscoli, C. Riccardi (Perugia) |
| P-10/3 | Role of Glucocorticoid-induced
leucine zipper (GILZ) in the control of inflammation induced by spinal cord
injury. M. Di Sante, S. Cuzzocrea, M. Galuppo, S. Bruscoli, E. Velardi, C. Riccardi (Perugia, Messina) |
| P-10/4 | GITR gene deletion and GITR-Fc soluble protein administration
inhibit multiple organ failure induced by zymosan A. Venanzi, M. Galuppo, G. Nocentini, E. Mazzon, E. Esposito, L. Riccardi, R. Di Paola, S. Bruscoli, C. Riccardi (Perugia, Messina) |
| P-10/5 | ApoA-I mimetic
peptide P2a restores cholesterol esterification during inflammation and
unmasks Apo A-I anti-inflammatory endogenous activity in vivo V. Vellecco, M. Bucci, L. Cigliano, A. Rossi, L. Sautebin, F. Roviezzo, P. Abrescia, C. Pedone , G. Cirino (Napoli) |
| P-10/6 | Anti-inflammatory
properties of clovamide and Theobroma cacao phenolic extracts in
human monocytes: evaluation of respiratory burst, cytokine release, NF-κ B
activation and PPARγ C. Bardelli, H.W. Zeng, M. Locatelli, A. Amoruso, J.D. Coisson, F. Travaglia, M. Arlorio, S. Brunelleschi (Novara, Shangai) |
| P-10/7 | A possible
involvment of Monocyte-derived MicroParticles (MdMP) in alveolar macrophages
inflammatory response A. Amoruso, P. Balbo, C. Bardelli, D. Federici-Canova, LG. Fresu, S. Brunelleschi (Novara) |
| P-10/8 | Expression of PPARϒ in monocyte and monocyte-derived macrophage
(MDM) in patients with Rheumatoid Arthritis A. Palma, PP. Sainaghi, LG. Fresu, S. Brunelleschi, G.C. Avanzi (Novara) |
| P-10/9 | Anti-inflammatory Effects of the CINOD NCX 429 in Human Monocytes
and Macrophages D. Federici Canova, A. Amoruso, L. Fresu, J. Padron, M. Bolla, S. Brunelleschi (Novara, Milano) |
| P-10/10 | PAR-2 (Proteinase-activated receptors 2) mediates arterial
vasorelaxation in systemic sclerosis F. Roviezzo, L. De Gruttola, A. Bertolino, V. Vellecco, B. D\'Agostino, V. Brancaleone, M. Bucci, G. Cirino (Napoli) |
| P-10/11 | Effects of flavocoxid, a dual
inhibitor of cyclooxygenase and 5-lipoxygenase enzymes, on benign prostatic
hyperplasia. A. Bitto, D. Altavilla, N. Irrera, F. Polito, S. Arena, L. Minutoli, H. Marini, F. Squadrito (Messina) |
| P-10/12 | Pharmacological properties of N-(1-carbamoyl-2-phenyl-ethyl)butyramidea
new synthetic butyrate prodrug in inhibiting gastrointestinal transit,
castor oil-induced diarrhoea and dextran sulfate sodium (DSS)-induced
colitis. R. Russo, G. D'Agostino, G. Mattace Raso, G. |
| P-10/13 | PPAR-α mediates
the anti-inflammatory effect of simvastatin in an experimental model of zymosan-induced multiple organ failure M. Donniacuo, B. Rinaldi, E. Esposito, A. Capuano, L. Sodano, E. Mazzon, D. Di Palma, I. Paterniti, G. Gritti, S. Cuzzocrea, F. Rossi (Naples, Messina) |
| P-10/14 | Evaluation of
biochemical features in nasal polyposis V. Carriero, S. Racca, G. Abbadessa, C. Ondolo, S. Aversa, S. Conticello, F. Di Carlo (Torino) |
| P-10/15 | Morphometric analysis and
evaluation of cellular inflammatory population in a model of mouse skin wound
healing G. Santo, N. D'Atanasio , A. Capezzone de Joannon, L. Durando (Roma) |
| P-10/16 | Does acyl CoA thioesterase 7
affect macrophage inflammatory phenotype? C. Bolego, T. Nishizawa, K.E. Bornfeldt (padova, Tokyo, |
| P-10/17 | Protective effects ofthe
poliaminocarboxylic compound Mn(II)Me2DO2A in osteoarticular pain models. L. Di Cesare Mannelli, D. Bani, A. Bencini, B. Valtancoli, G. Biffi Gentili, M. Zanardelli, C. Ghelardini, P. Failli (Firenze) |
| P-10/18 | A novel cross talk in resolution:
H2S activates the Annexin A1 pathway V. Brancaleone, A. Sampaio, R. Flower, G. Cirino, M. Perretti ( |
| P-10/19 | NF-kB decoy ODN released from respirable and biodegradable
PEI/PLGA particles inhibits MUC2 expression in LPS-stimulated human lung
cells D. De Stefano, F. Ungaro, C. Giovino, A. Polimeno, F. Quaglia, R. Carnuccio (Napoli) |
| P-10/20 | Cell Lines
Characterization for MCP-3/CCL7 Expression and Production in Response to Proinflammatory Stimuli E. Castelli, C. Apicella, C. Bartella, G. Innocente, M. Vitiello, F. Mancini, I. Coletta, G. Mangano, L. Durando, A. Guglielmotti (Roma) |
| P-10/21 | Set Up of an in vitro Model to Evaluate Potential
Inhibitors of IL-12p40 and TNF-α C. Bartella, C. Apicella, E. Castelli, G. Innocente, M. Vitiello, N. D’Atanasio, E. Teveroni, F. Mancini, I. Coletta, G. Mangano, A. Capezzone de Joannon, C. Milanese (Roma) |
| P-10/22 | Pharmacological characterization of the novel microsomal
prostaglandin(PG)E synthase-1 inhibitor AF3485 L. Di Francesco, A. Bruno, E. Ricciotti, M. Dovizio, E. Marcantoni, P. Anzellotti, B. Garrone, C. Milanese, I. Coletta, P. Patrignani (Chieti, Philadelphia, Roma) |
| P-10/23 | The ocular antiallergic action of mapracorat, a novel selective glucocorticoid
receptor agonist, involves eosinophils and mast cells: evidence from
human cells in vitro and an animal model M. Baiula, A. Spartà, A. Bedini, G. Carbonari, C. Bucolo, K.W. Ward, J-Z. Zhang, P. Govoni, S. Spampinato (Bologna, Trento, Catania, Rochester, Parma) |
| P-10/24 | Novel
antagonists of αvβ3, α5β1 and α4β1 integrins: attractive targets for cancer and anti-inflammatory therapeutics S.D. Dattoli, M. Baiula, A. Viola, R. De Marco, S. Spampinato (Bologna) |
| P-10/25 | Effect of a
chronic treatment with Resveratrol on in vivo and ex vivo pathological signs
of dystrophic mdx mouse R.F. Capogrosso, A. Cozzoli, V. Sblendorio, S. Gagliardi, V. Longo, M. Montagnani, B. Nico, A. De Luca (Bari) |
| P-10/26 | Effect of palmitoylethanolamide in
combination with luteolin on oxidative stress in vitro: modification of inflammatory response and
apoptosis E. Esposito, S. Cuzzocrea ( Messina) |
| P-10/27 | Xolair, a New
Monoclonal Drug Anti-IgE Antibody for the Treatment of Allergic Asthma M. Di Domenico, A. Bisogno, M. Polverino, C. De Rosa, V. Ricci, A. Capasso (Salerno, Cava dè Tirreni) |
| P-10/28 | Visfatin/NAMPT/PBEF and
inflammatory-related diseases: a study on patients with essential obesity. R. Zaninetti, R. Rahimian, A. Amoruso, P. Marzullo, PL. Canonico, S. Brunelleschi, L. Fresu, A.A. Genazzani (Novara, Tehran) |
| P-10/29 | Palmithoylethanolamide inhibits
release of nerve growth factor by inflammation-activated mast cells via the
GPR55 orphan receptor M. Scollo, G. Cantarella, R. Bernardini ( |
| P-10/30 | Estrogen
signaling pathway in inflammatory cells E. Vegeto, A. Maggi (Milano) |
| P-10/31 | Ultrapotent
effects of salvinorin A on LPS-stimulated murine
macrophages and its antinflammatory action in vivo G. Aviello, F. Borrelli, F. Guida, B. Romano, M. De Chiaro, J.K. Zjawiony, S. Maione , A.A. Izzo, R. Capasso (Naples, University (MS, USA)) |
| P-10/32 | Transient Receptor Potential
Ankyrin 1 (TRPA1) is expressed in non-neuronal pulmonary cells and underlies
IL-8 release elicited by cigarette smoke and other irritants. S. Materazzi, R. Nassini, P. Pedretti, N. Moretto, C. Fusi, G. Volpi, R. Patacchini, P. Geppetti (Firenze, Parma) |